Wouldn’t they want to land big contracts which would allow them to defend their contract better by actually performing versus going slow roll with DMK in the mix now . Then we could clean up the partnership in the US and let DMK take the reigns in Europe ? I can’t get my head around shelving symjepi forever . All the work and capital that went into it and to shelve it forever with so much BS around big pharma and generic epi getting dummied in the courts with price fixing .